Research & Development In Brief: smokers and beta carotene; PUFA-enriched formula; antioxidants no boost for conception; vitamin D misses on blood pressure
This article was originally published in The Tan Sheet
Executive Summary
Smokers’ beta carotene-mortality connection explored; PUFA-enriched infant formula speeds processing; antioxidants do not boost conception chances; and vitamin D does not lower blood pressure.
You may also be interested in...
Antioxidants/Cancer Health Claim Contradicted By ATBC Study - FDA
Analyses from the 1994 Alpha-Tocopherol, Beta Carotene intervention trial raise "serious questions" about vitamin E's role in modifying cancer risk, FDA's Center for Food Safety & Applied Nutrition concludes May 4 in rejecting an antioxidant vitamins/cancer health claim.
CARET trial subgroup data suggest lung cancer link to alcohol use among smokers.
BETA CAROTENE LINK TO LUNG CANCER MAY BE INFLUENCED BY ALCOHOL CONSUMPTION among smokers, suggests a new analysis of the Beta Carotene and Retinol Efficacy Trial (CARET) published in the Nov. 6 issue of the Journal of the National Cancer Institute. CARET, a six-center chemoprevention trial, was halted 21 months early because of interim data showing evidence of no benefit and possible harm in participants taking beta carotene (30 mg) and vitamin A (25,000 IU) daily for an average of four years ("The Tan Sheet" Jan. 22, p. 4). The study found 28% more lung cancers and 17% more deaths in the supplement group compared to the placebo group.
J&J Consumer Sales Slip Even As Recalled Brands, Seasonal Items Reach Stores
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.